semaglutide wellington with Glycine Semaglutide – SP Aesthetics

Do not discontinue medication without medical advice : GLP-1 receptor agonists provide important therapeutic benefits for diabetes control and cardiovascular risk reduction

Which Patient Should Choose Which GLP-1 Option Patients with established heart disease or multiple cardiovascular risk factors (high blood pressure, high cholesterol, diabetes) benefit most from GLP-1 agonist therapy

PLoS One 2019;14:e0213508.ArticlePubMedPMC 66

For instance, tirzepatide, a dual GLP-1/GIP receptor agonist, has shown even more pronounced effects on weight reduction than GLP1-RAs alone, with clinical trials reporting weight loss exceeding 15% from baseline

This is when people typically see substantial changes in how their body looks and feels

Franks SE, Campbell CI, Barnett EF, Siwicky MD, Livingstone J, Cory S, et al